Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (988) Genomics and Bioinformatics for Clinical Use (121)

Published on in Vol 8, No 8 (2019): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13848, first published .
Woman's hand holding a pill and a glass of blue liquid

Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study

Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study

Authors of this article:

Beatriz Manzor Mitrzyk1 Author Orcid Image ;   Reema Kadri2 Author Orcid Image ;   Karen B Farris1 Author Orcid Image ;   Vicki L Ellingrod1 Author Orcid Image ;   Michael S Klinkman2 Author Orcid Image ;   Mack T Ruffin IV3 Author Orcid Image ;   Melissa A Plegue2 Author Orcid Image ;   Lorraine R Buis2 Author Orcid Image
Article Authors Cited by (3) Tweetations (2) Metrics

Journals

  1. Jukic M, Milosavljević F, Molden E, Ingelman-Sundberg M. Pharmacogenomics in treatment of depression and psychosis: an update. Trends in Pharmacological Sciences 2022;43(12):1055 View
  2. Roberts B, Cooper Z, Miljevic A, Stanley S, Majda B, Collins K, Baltic S, Lindsey-Temple S, Akkari P, Hood S, Rodger J. PharmacoGENEtics in Youth Depression (GENE-YD) Study protocol: a pilot triple-blinded randomised controlled trial using pharmacogenetics to tailor antidepressant treatment in young Australians. BMJ Open 2025;15(11):e103644 View
  3. Roberts B, Cooper Z, Miljevic A, Stanley S, Majda B, Collins K, Woodland S, Kyron M, Baltic S, Temple S, Akkari P, Hood S, Rodger J. The pharmacogGENEtics in Youth Depression (GENE-YD) study for personalizing antidepressant pharmacotherapy for young Western Australians – A feasibility study. Translational Psychiatry 2026;16(1) View